Global Clinical Data Analytics Market Overview:

Clinical data analytics plays an essential role in curing diseases, improving the quality of care in the healthcare sector, predicting diseases, and preventing deaths due to chronic diseases. It helps to accumulate patient information and analyze it, statistically and with quality, to establish models to define and predict current and future trends. It includes collecting, retaining, and analyzing sensitive clinical data to improve its effectiveness, thus assisting caregivers in providing preventive and customized care to patients. As a result, its deployment aid in improving the overall patient quality of care across diverse healthcare settings, such as hospitals, clinics and ambulatory surgery centers (ASCs). 

The global clinical data analytics market reached a value of US$ 10.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 77.3 Billion by 2027, exhibiting at a CAGR of 38.7% during 2022-2027. 

The COVID 19 pandemic has positively affected the clinical data analytics market. Digital health and telehealth have geared up during the pandemic. The spread of the virus re-emphasized the importance of remote diagnosis, care, and consultation. The worldwide lockdown also mandated online consultation of patients with moderate symptoms. Medical IoT devices with patients at home are being utilized for optimizing outpatient treatment and minimizing repeat visits. Additionally, these devices can be further used in a crisis as well. COVID-19 has strengthened the market’s growth as more healthcare sectors have adopted digital transformation.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/clinical-data-analytics-market/requestsample

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Clinical Data Analytics Market Trends:

The global market is majorly driven by the rising prevalence of cardiac disorders and other chronic disorders. In line with this, rapid advancements in clinical data analytics are positively influencing the market. Furthermore, the increasing adoption of EHRs and improved quality of care are creating a positive outlook for the market. Moreover, the growing healthcare expenditure is fueling the market. Besides this, the integration of artificial intelligence and machine learning in clinical data analytics acts as another major growth-inducing factor. Additionally, the advent of mHealth technology, where user-reported data, task-based measurements, and passive sensing help acquire the data used for clinical data analysis, is propelling the market growth.

Global Clinical Data Analytics Market 2022-2027 Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the industry has also been examined along with the profiles of the key players being

• Allscripts Healthcare Solutions Inc
• CareEvolution LLC
• Cerner Corporation
• Health Catalyst
• International Business Machines Corporation
• InterSystems Corporation
• Koninklijke Philips N.V
• Medeanalytics Inc.
• Sisense Inc.
• UnitedHealth Group Incorporated
• Xerox Holdings Corporation.

Breakup by Solution:

• Software
• Services

Breakup by Deployment Mode:

• Cloud-based
• On-premises

Breakup by Application:

• Quality Improvement and Clinical Benchmarking
• Clinical Decision Support
• Regulatory Reporting and Compliance
• Comparative Analytics
• Precision Health

Breakup by End User:

• Pharmaceutical Companies
• Healthcare Organizations
• Research Organizations
• Government Organizations

 Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800